{"id":55908,"date":"2025-02-07T08:59:17","date_gmt":"2025-02-07T11:59:17","guid":{"rendered":"https:\/\/mindthegraph.com\/blog\/?p=55908"},"modified":"2025-02-25T09:05:25","modified_gmt":"2025-02-25T12:05:25","slug":"incidence-vs-prevalence","status":"publish","type":"post","link":"https:\/\/mindthegraph.com\/blog\/sk\/incidence-vs-prevalence\/","title":{"rendered":"<strong>Incidencia vs. prevalencia: K\u013e\u00fa\u010dov\u00e9 ukazovatele pre meranie chor\u00f4b<\/strong>"},"content":{"rendered":"<p>Pochopenie rozdielu medzi incidenciou a prevalenciou je k\u013e\u00fa\u010dov\u00e9 pre sledovanie \u0161\u00edrenia chor\u00f4b a pl\u00e1novanie \u00fa\u010dinn\u00fdch strat\u00e9gi\u00ed v oblasti verejn\u00e9ho zdravia. T\u00e1to pr\u00edru\u010dka objas\u0148uje k\u013e\u00fa\u010dov\u00e9 rozdiely medzi incidenciou a prevalenciou a pon\u00faka poh\u013ead na ich v\u00fdznam v epidemiol\u00f3gii. Incidencia meria v\u00fdskyt nov\u00fdch pr\u00edpadov za ur\u010dit\u00e9 obdobie, zatia\u013e \u010do prevalencia poskytuje preh\u013ead o v\u0161etk\u00fdch existuj\u00facich pr\u00edpadoch v ur\u010ditom okamihu. Objasnenie rozdielu medzi t\u00fdmito pojmami preh\u013abi va\u0161e pochopenie toho, ako ovplyv\u0148uj\u00fa strat\u00e9gie verejn\u00e9ho zdravia a usmer\u0148uj\u00fa z\u00e1sadn\u00e9 rozhodnutia v oblasti zdravotnej starostlivosti.<\/p>\n\n\n\n<h2><strong>K\u013e\u00fa\u010dov\u00e9 poznatky: Incidencia vs. prevalencia pri sledovan\u00ed ochoren\u00ed<\/strong><\/h2>\n\n\n\n<p>Incidencia a prevalencia s\u00fa z\u00e1kladn\u00e9 epidemiologick\u00e9 ukazovatele, ktor\u00e9 poskytuj\u00fa inform\u00e1cie o frekvencii ochoren\u00ed a usmer\u0148uj\u00fa intervencie v oblasti verejn\u00e9ho zdravia. Hoci obe poskytuj\u00fa cenn\u00e9 inform\u00e1cie o zdravotnom stave popul\u00e1cie, pou\u017e\u00edvaj\u00fa sa na zodpovedanie r\u00f4znych ot\u00e1zok a po\u010d\u00edtaj\u00fa sa odli\u0161n\u00fdmi sp\u00f4sobmi. Pochopenie rozdielu medzi incidenciou a prevalenciou pom\u00e1ha pri anal\u00fdze trendov ochoren\u00ed a pl\u00e1novan\u00ed \u00fa\u010dinn\u00fdch intervenci\u00ed v oblasti verejn\u00e9ho zdravia.<\/p>\n\n\n\n<h3><strong>V\u00fdskyt: Meranie nov\u00fdch pr\u00edpadov v priebehu \u010dasu<\/strong><\/h3>\n\n\n\n<p>Incidencia meria v\u00fdskyt nov\u00fdch pr\u00edpadov v r\u00e1mci popul\u00e1cie za ur\u010dit\u00e9 obdobie, \u010d\u00edm poukazuje na riziko a r\u00fdchlos\u0165 prenosu ochorenia. Meria, ako \u010dasto sa objavuj\u00fa nov\u00e9 pr\u00edpady, \u010d\u00edm poukazuje na riziko n\u00e1kazy ochoren\u00edm v ur\u010ditom \u010dasovom r\u00e1mci.<\/p>\n\n\n\n<p>V\u00fdskyt pom\u00e1ha pochopi\u0165, ako r\u00fdchlo sa choroba \u0161\u00edri, a identifikova\u0165 nov\u00e9 zdravotn\u00e9 hrozby. Je obzvl\u00e1\u0161\u0165 u\u017eito\u010dn\u00e1 pri \u0161t\u00fadiu infek\u010dn\u00fdch chor\u00f4b alebo stavov s r\u00fdchlym n\u00e1stupom.<\/p>\n\n\n\n<p><strong>V\u00fdpo\u010det incidencie<\/strong>:<br>Vzorec pre v\u00fdskyt je jednoduch\u00fd:<\/p>\n\n\n\n<p>Incidencia = po\u010det nov\u00fdch pr\u00edpadov v ur\u010ditom \u010dasovom obdob\u00edPopul\u00e1cia v riziku po\u010das toho ist\u00e9ho obdobia<\/p>\n\n\n\n<p><strong>Prvky<\/strong>:<\/p>\n\n\n\n<p><strong>Nov\u00e9 pr\u00edpady<\/strong>: Iba pr\u00edpady, ktor\u00e9 sa vyskytn\u00fa po\u010das ur\u010den\u00e9ho \u010dasov\u00e9ho obdobia.<\/p>\n\n\n\n<p><strong>Ohrozen\u00e1 popul\u00e1cia<\/strong>: Skupina os\u00f4b, ktor\u00e9 s\u00fa na za\u010diatku \u010dasov\u00e9ho obdobia bez ochorenia, ale s\u00fa n\u00e1chyln\u00e9 na ochorenie.<\/p>\n\n\n\n<p>Napr\u00edklad, ak sa v priebehu roka vyskytne 200 nov\u00fdch pr\u00edpadov ochorenia v popul\u00e1cii 10 000 \u013eud\u00ed, miera v\u00fdskytu bude:<\/p>\n\n\n\n<p>200\/(10 000)=0,02 alebo 2%<\/p>\n\n\n\n<p>To znamen\u00e1, \u017ee v danom roku sa choroba vyskytla u 2% popul\u00e1cie.<\/p>\n\n\n\n<h3><strong>Prevalencia: Zachytenie cel\u00e9ho rozsahu ochorenia<\/strong><\/h3>\n\n\n\n<p>Prevalencia sa vz\u0165ahuje na celkov\u00fd po\u010det pr\u00edpadov konkr\u00e9tnej choroby alebo stavu, nov\u00fdch aj u\u017e existuj\u00facich, v popul\u00e1cii v ur\u010ditom \u010dase (alebo za ur\u010dit\u00e9 obdobie). Na rozdiel od incidencie, ktor\u00e1 meria mieru nov\u00fdch pr\u00edpadov, prevalencia zachyt\u00e1va celkov\u00fa z\u00e1\u0165a\u017e ochorenia v popul\u00e1cii vr\u00e1tane \u013eud\u00ed, ktor\u00ed s dan\u00fdm ochoren\u00edm \u017eij\u00fa u\u017e nejak\u00fd \u010das, a t\u00fdch, u ktor\u00fdch sa pr\u00e1ve objavilo.<\/p>\n\n\n\n<figure class=\"wp-block-image alignwide size-full\"><a href=\"https:\/\/mindthegraph.com\/poster-maker\/?utm_source=blog&amp;utm_medium=banners&amp;utm_campaign=conversion\"><img decoding=\"async\" loading=\"lazy\" width=\"651\" height=\"174\" src=\"https:\/\/mindthegraph.com\/blog\/wp-content\/uploads\/2024\/06\/mind-the-graph.png\" alt=\"&quot;Propaga\u010dn\u00fd banner pre Mind the Graph s n\u00e1pisom &quot;Vytv\u00e1rajte vedeck\u00e9 ilustr\u00e1cie bez n\u00e1mahy s Mind the Graph&quot;, ktor\u00fd zd\u00f4raz\u0148uje jednoduchos\u0165 pou\u017e\u00edvania platformy.&quot;\" class=\"wp-image-54656\" srcset=\"https:\/\/mindthegraph.com\/blog\/wp-content\/uploads\/2024\/06\/mind-the-graph.png 651w, https:\/\/mindthegraph.com\/blog\/wp-content\/uploads\/2024\/06\/mind-the-graph-300x80.png 300w, https:\/\/mindthegraph.com\/blog\/wp-content\/uploads\/2024\/06\/mind-the-graph-18x5.png 18w, https:\/\/mindthegraph.com\/blog\/wp-content\/uploads\/2024\/06\/mind-the-graph-100x27.png 100w\" sizes=\"(max-width: 651px) 100vw, 651px\" \/><\/a><figcaption class=\"wp-element-caption\">Vytv\u00e1rajte vedeck\u00e9 ilustr\u00e1cie bez n\u00e1mahy pomocou <a href=\"https:\/\/mindthegraph.com\/poster-maker\/?utm_source=blog&amp;utm_medium=banners&amp;utm_campaign=conversion\">Mind the Graph<\/a>.<\/figcaption><\/figure>\n\n\n\n<p>Prevalencia sa \u010dasto vyjadruje ako podiel popul\u00e1cie a poskytuje obraz o tom, ako je choroba roz\u0161\u00edren\u00e1. Pom\u00e1ha pri posudzovan\u00ed rozsahu chronick\u00fdch ochoren\u00ed a in\u00fdch dlhodob\u00fdch zdravotn\u00fdch probl\u00e9mov, \u010do umo\u017e\u0148uje syst\u00e9mom zdravotnej starostlivosti efekt\u00edvne rozde\u013eova\u0165 zdroje a pl\u00e1nova\u0165 dlhodob\u00fa starostlivos\u0165.<\/p>\n\n\n\n<p><strong>V\u00fdpo\u010det prevalencie<\/strong>:<br>Vzorec na v\u00fdpo\u010det prevalencie je:<\/p>\n\n\n\n<p>Prevalencia=Celkov\u00fd po\u010det pr\u00edpadov (nov\u00fdch + existuj\u00facich)Celkov\u00e1 popul\u00e1cia v tom istom \u010dase<\/p>\n\n\n\n<p><strong>Prvky<\/strong>:<\/p>\n\n\n\n<p><strong>Celkov\u00fd po\u010det pr\u00edpadov<\/strong>: Zah\u0155\u0148a v\u0161etk\u00fdch v popul\u00e1cii, ktor\u00ed maj\u00fa chorobu alebo stav v ur\u010ditom \u010dasovom okamihu, a to ako nov\u00e9, tak aj predt\u00fdm diagnostikovan\u00e9 pr\u00edpady.<\/p>\n\n\n\n<p><strong>Celkov\u00fd po\u010det obyvate\u013eov<\/strong>: Cel\u00e1 skupina sk\u00faman\u00fdch os\u00f4b, vr\u00e1tane os\u00f4b s ochoren\u00edm aj bez neho.<\/p>\n\n\n\n<p>Napr\u00edklad, ak 300 \u013eud\u00ed z 5 000 obyvate\u013eov trp\u00ed ur\u010ditou chorobou, prevalencia bude:<\/p>\n\n\n\n<p>300\/(5 000)=0,06 alebo 6%<\/p>\n\n\n\n<p>To znamen\u00e1, \u017ee v s\u00fa\u010dasnosti je touto chorobou postihnut\u00fdch 6% popul\u00e1cie.<\/p>\n\n\n\n<p>Prevalenciu mo\u017eno \u010falej rozdeli\u0165 na:<\/p>\n\n\n\n<p><strong>Bodov\u00e1 prevalencia<\/strong>: Podiel popul\u00e1cie postihnutej chorobou v jednom \u010dasovom okamihu.<\/p>\n\n\n\n<p><strong>Prevalencia obdobia<\/strong>: Podiel popul\u00e1cie postihnutej po\u010das ur\u010dit\u00e9ho obdobia, napr\u00edklad po\u010das jedn\u00e9ho roka.<\/p>\n\n\n\n<p>Prevalencia je obzvl\u00e1\u0161\u0165 u\u017eito\u010dn\u00e1 na pochopenie chronick\u00fdch ochoren\u00ed, ako je cukrovka alebo srdcov\u00e9 ochorenie, ke\u010f \u013eudia \u017eij\u00fa s chorobou dlh\u00e9 obdobie a syst\u00e9my zdravotnej starostlivosti musia zvl\u00e1da\u0165 s\u00fa\u010dasn\u00e9 aj prebiehaj\u00face pr\u00edpady.<\/p>\n\n\n\n<h2><strong>Incidencia vs. prevalencia<\/strong><\/h2>\n\n\n\n<p>Hoci incidencia aj prevalencia s\u00fa d\u00f4le\u017eit\u00e9 pre pochopenie vzorcov ochorenia, meraj\u00fa r\u00f4zne aspekty frekvencie ochorenia. K\u013e\u00fa\u010dov\u00e9 rozdiely medzi t\u00fdmito dvoma ukazovate\u013emi spo\u010d\u00edvaj\u00fa v \u010dasovom r\u00e1mci, na ktor\u00fd sa vz\u0165ahuj\u00fa, a v sp\u00f4sobe ich pou\u017eitia vo verejnom zdrav\u00ed a v\u00fdskume.<\/p>\n\n\n\n<h3><strong>\u010casov\u00fd r\u00e1mec<\/strong><\/h3>\n\n\n\n<p><strong>V\u00fdskyt<\/strong>:<br>Incidencia meria po\u010det nov\u00fdch pr\u00edpadov ochorenia, ktor\u00e9 sa vyskytn\u00fa v ur\u010ditej popul\u00e1cii za ur\u010dit\u00e9 \u010dasov\u00e9 obdobie (napr. mesiac, rok). To znamen\u00e1, \u017ee incidencia je v\u017edy spojen\u00e1 s \u010dasov\u00fdm r\u00e1mcom, ktor\u00fd odr\u00e1\u017ea mieru v\u00fdskytu nov\u00fdch pr\u00edpadov. Ukazuje, ako r\u00fdchlo sa choroba \u0161\u00edri alebo ak\u00e9 je riziko vzniku ochorenia v r\u00e1mci stanoven\u00e9ho obdobia.<\/p>\n\n\n\n<p>Zameriavame sa na identifik\u00e1ciu za\u010diatku ochorenia. Sledovanie nov\u00fdch pr\u00edpadov umo\u017e\u0148uje z\u00edska\u0165 preh\u013ead o r\u00fdchlosti prenosu ochorenia, \u010do je ve\u013emi d\u00f4le\u017eit\u00e9 pre \u0161t\u00fadium ohn\u00edsk n\u00e1kazy, hodnotenie prevent\u00edvnych programov a pochopenie rizika n\u00e1kazy.<\/p>\n\n\n\n<p><strong>Prevalencia<\/strong>:<br>Na druhej strane prevalencia meria celkov\u00fd po\u010det pr\u00edpadov (nov\u00fdch aj existuj\u00facich) v popul\u00e1cii v ur\u010ditom \u010dasovom okamihu alebo za ur\u010dit\u00e9 obdobie. Poskytuje preh\u013ead o tom, ako je choroba roz\u0161\u00edren\u00e1, a pon\u00faka obraz o celkovom vplyve choroby na popul\u00e1ciu v danom okamihu.<\/p>\n\n\n\n<p>Prevalencia vyjadruje d\u013a\u017eku trvania aj hromadenie pr\u00edpadov, \u010do znamen\u00e1, \u017ee odr\u00e1\u017ea, ko\u013eko \u013eud\u00ed \u017eije s t\u00fdmto ochoren\u00edm. Je u\u017eito\u010dn\u00e1 na pochopenie celkovej z\u00e1\u0165a\u017ee ochorenia, najm\u00e4 v pr\u00edpade chronick\u00fdch alebo dlhotrvaj\u00facich ochoren\u00ed.<\/p>\n\n\n\n<h3><strong>Aplik\u00e1cia<\/strong><\/h3>\n\n\n\n<p><strong>V\u00fdskyt<\/strong>:<br>Incidencia sa be\u017ene pou\u017e\u00edva vo verejnom zdravotn\u00edctve a epidemiologickom v\u00fdskume na \u0161t\u00fadium rizikov\u00fdch faktorov a pr\u00ed\u010din chor\u00f4b. Pom\u00e1ha ur\u010di\u0165, ako sa choroba vyv\u00edja a ako r\u00fdchlo sa \u0161\u00edri, \u010do je nevyhnutn\u00e9 pre:<\/p>\n\n\n\n<ul>\n<li>monitorovanie epid\u00e9mi\u00ed alebo ohn\u00edsk n\u00e1kazy (napr. sledovanie \u0161\u00edrenia COVID-19 alebo chr\u00edpky).<\/li>\n\n\n\n<li>Hodnotenie \u00fa\u010dinnosti prevent\u00edvnych opatren\u00ed (napr. o\u010dkovania alebo z\u00e1sahov v oblasti verejn\u00e9ho zdravia).<\/li>\n\n\n\n<li>Identifik\u00e1cia rizikov\u00fdch faktorov ochoren\u00ed (napr. ur\u010denie, \u010di ur\u010dit\u00e9 faktory \u017eivotn\u00e9ho \u0161t\u00fdlu zvy\u0161uj\u00fa pravdepodobnos\u0165 vzniku rakoviny alebo srdcov\u00fdch ochoren\u00ed).<\/li>\n<\/ul>\n\n\n\n<p>\u00dadaje o v\u00fdskyte pom\u00e1haj\u00fa ur\u010di\u0165 priority v oblasti zdravotn\u00fdch zdrojov na kontrolu nov\u00fdch chor\u00f4b a m\u00f4\u017eu by\u0165 podkladom pre strat\u00e9gie na zn\u00ed\u017eenie prenosu.<\/p>\n\n\n\n<p><strong>Prevalencia<\/strong>:<br>Prevalencia sa \u0161iroko pou\u017e\u00edva v zdravotnej politike, pl\u00e1novan\u00ed a pride\u013eovan\u00ed zdrojov na pochopenie celkov\u00e9ho za\u0165a\u017eenia chorobami, najm\u00e4 chronick\u00fdmi stavmi. Je obzvl\u00e1\u0161\u0165 cenn\u00e1 pre:<\/p>\n\n\n\n<ul>\n<li>Odhad po\u010dtu \u013eud\u00ed \u017eij\u00facich s dlhodob\u00fdmi ochoreniami (napr. cukrovka, hypertenzia alebo du\u0161evn\u00e9 poruchy).<\/li>\n\n\n\n<li>pl\u00e1novanie zdravotn\u00edckych slu\u017eieb a zariaden\u00ed (napr. pride\u013eovanie zdrojov na lie\u010dbu ochoren\u00ed s vysokou prevalenciou, ako je obezita alebo astma).<\/li>\n\n\n\n<li>navrhovanie a hodnotenie programov verejn\u00e9ho zdravia zameran\u00fdch na zvl\u00e1danie prebiehaj\u00facich ochoren\u00ed (napr. vytv\u00e1ranie dlhodob\u00fdch pl\u00e1nov zvl\u00e1dania ochoren\u00ed, ktor\u00e9 postihuj\u00fa ve\u013ek\u00fa \u010das\u0165 popul\u00e1cie).<\/li>\n<\/ul>\n\n\n\n<p>\u00dadaje o prevalencii podporuj\u00fa tvorcov polit\u00edk pri ur\u010dovan\u00ed prior\u00edt zdravotn\u00edckych slu\u017eieb na z\u00e1klade celkov\u00e9ho po\u010dtu postihnutej popul\u00e1cie, \u010d\u00edm sa zabezpe\u010d\u00ed dostato\u010dn\u00e1 zdravotn\u00e1 starostlivos\u0165 a zdroje pre s\u00fa\u010dasn\u00fdch aj bud\u00facich pacientov.<\/p>\n\n\n\n<p>Incidencia meria po\u010det nov\u00fdch pr\u00edpadov ochorenia, ktor\u00e9 sa vyskytli v ur\u010ditom \u010dasovom r\u00e1mci, \u010do je cenn\u00e9 pre pochopenie rizika ochorenia a miery \u0161\u00edrenia, zatia\u013e \u010do prevalencia kvantifikuje celkov\u00fd po\u010det pr\u00edpadov v ur\u010ditom \u010dasovom bode, \u010do poskytuje preh\u013ead o celkovej z\u00e1\u0165a\u017ei ochorenia a pom\u00e1ha pri dlhodobom pl\u00e1novan\u00ed zdravotnej starostlivosti. Incidencia a prevalencia spolo\u010dne pon\u00fakaj\u00fa doplnkov\u00e9 poznatky, ktor\u00e9 umo\u017e\u0148uj\u00fa komplexnej\u0161ie pochopenie zdravotn\u00e9ho stavu popul\u00e1cie a umo\u017e\u0148uj\u00fa \u00faradn\u00edkom verejn\u00e9ho zdravotn\u00edctva \u00fa\u010dinne rie\u0161i\u0165 okam\u017eit\u00e9 aj trval\u00e9 zdravotn\u00e9 probl\u00e9my.<\/p>\n\n\n\n<h2><strong>Pr\u00edklady<\/strong><\/h2>\n\n\n\n<h3><strong>Incidencia v akcii<\/strong><\/h3>\n\n\n\n<p>Re\u00e1lny pr\u00edklad v\u00fdskytu v praxi mo\u017eno pozorova\u0165 po\u010das vypuknutia vt\u00e1\u010dej chr\u00edpky (avi\u00e1rnej influenzy) na hydinovej farme. \u00daradn\u00edci verejn\u00e9ho zdravotn\u00edctva m\u00f4\u017eu po\u010das epid\u00e9mie sledova\u0165 po\u010det nov\u00fdch pr\u00edpadov vt\u00e1\u010dej chr\u00edpky hl\u00e1sen\u00fdch ka\u017ed\u00fd t\u00fd\u017ede\u0148 v k\u0155d\u013eoch. Ak napr\u00edklad hydin\u00e1rska farma s 5 000 vt\u00e1kmi nahl\u00e1si 200 nov\u00fdch pr\u00edpadov vt\u00e1\u010dej chr\u00edpky v priebehu jedn\u00e9ho mesiaca, vypo\u010d\u00edta sa miera v\u00fdskytu, aby sa ur\u010dilo, ako r\u00fdchlo sa v\u00edrus v tejto popul\u00e1cii \u0161\u00edri. Tieto inform\u00e1cie s\u00fa rozhoduj\u00face pre zdravotn\u00edcke org\u00e1ny pri zav\u00e1dzan\u00ed kontroln\u00fdch opatren\u00ed, ako je napr\u00edklad vyra\u010fovanie infikovan\u00fdch vt\u00e1kov, presadzovanie karant\u00e9n a vzdel\u00e1vanie pracovn\u00edkov fariem o postupoch biologickej bezpe\u010dnosti s cie\u013eom zabr\u00e1ni\u0165 \u010fal\u0161iemu prenosu choroby. Viac inform\u00e1ci\u00ed o vt\u00e1\u010dej chr\u00edpke n\u00e1jdete v tomto zdroji:<a href=\"https:\/\/mindthegraph.com\/blog\/bird-flu\/\"> Preh\u013ead vt\u00e1\u010dej chr\u00edpky<\/a>.<\/p>\n\n\n\n<p>\u010eal\u0161\u00ed pr\u00edklad v\u00fdskytu v praxi mo\u017eno vidie\u0165 po\u010das epid\u00e9mie prasacej chr\u00edpky (H1N1) v komunite. \u00daradn\u00edci verejn\u00e9ho zdravotn\u00edctva m\u00f4\u017eu po\u010das chr\u00edpkovej sez\u00f3ny sledova\u0165 po\u010det nov\u00fdch pr\u00edpadov prasacej chr\u00edpky hl\u00e1sen\u00fdch medzi obyvate\u013emi ka\u017ed\u00fd t\u00fd\u017ede\u0148. Ak napr\u00edklad mesto so 100 000 obyvate\u013emi nahl\u00e1si 300 nov\u00fdch pr\u00edpadov prasacej chr\u00edpky za jeden mesiac, vypo\u010d\u00edta sa miera v\u00fdskytu, aby sa ur\u010dilo, ako r\u00fdchlo sa v\u00edrus v danej popul\u00e1cii \u0161\u00edri. Tieto inform\u00e1cie s\u00fa k\u013e\u00fa\u010dov\u00e9 pre zdravotn\u00edcke org\u00e1ny, aby mohli v\u010das zavies\u0165 opatrenia v oblasti verejn\u00e9ho zdravia, ako je spustenie o\u010dkovac\u00edch kampan\u00ed, odpor\u00fa\u010danie obyvate\u013eom, aby dodr\u017eiavali spr\u00e1vnu hygienu, a podpora informovanosti o pr\u00edznakoch s cie\u013eom podpori\u0165 v\u010dasn\u00e9 odhalenie a lie\u010dbu ochorenia. Sledovanie v\u00fdskytu pom\u00e1ha usmer\u0148ova\u0165 z\u00e1sahy, ktor\u00e9 m\u00f4\u017eu v kone\u010dnom d\u00f4sledku zn\u00ed\u017ei\u0165 prenos a chr\u00e1ni\u0165 zdravie komunity. \u010eal\u0161ie inform\u00e1cie o prasacej chr\u00edpke n\u00e1jdete na tomto odkaze:<a href=\"https:\/\/mindthegraph.com\/blog\/swine-flu\/\"> Preh\u013ead o prasacej chr\u00edpke<\/a>.&nbsp;<\/p>\n\n\n\n<h3><strong>Prevalencia v akcii<\/strong><\/h3>\n\n\n\n<p>Pr\u00edklad prevalencie v praxi mo\u017eno pozorova\u0165 v s\u00favislosti s lie\u010dbou cukrovky. V\u00fdskumn\u00edci v oblasti zdravotn\u00edctva m\u00f4\u017eu vykona\u0165 prieskum s cie\u013eom zisti\u0165 celkov\u00fd po\u010det os\u00f4b \u017eij\u00facich s cukrovkou v meste s 50 000 obyvate\u013emi v danom \u010dase. Ak by zistili, \u017ee 4 500 obyvate\u013eov m\u00e1 cukrovku, vypo\u010d\u00edtali by prevalenciu, ktor\u00e1 by uk\u00e1zala, \u017ee 9% obyvate\u013eov je postihnut\u00fdch t\u00fdmto chronick\u00fdm ochoren\u00edm. Tieto \u00fadaje o prevalencii s\u00fa k\u013e\u00fa\u010dov\u00e9 pre pl\u00e1nova\u010dov mesta a poskytovate\u013eov zdravotnej starostlivosti, preto\u017ee im pom\u00e1haj\u00fa pride\u013eova\u0165 zdroje na vzdel\u00e1vacie programy, kliniky pre lie\u010dbu cukrovky a podporn\u00e9 slu\u017eby s cie\u013eom efekt\u00edvne rie\u0161i\u0165 potreby postihnutej popul\u00e1cie.<\/p>\n\n\n\n<p>Podobn\u00e9 vyu\u017eitie prevalencie mo\u017eno pozorova\u0165 po\u010das pand\u00e9mie COVID-19, ke\u010f bolo pre pl\u00e1novanie verejn\u00e9ho zdravia nevyhnutn\u00e9 pozna\u0165 po\u010det akt\u00edvnych pr\u00edpadov v ur\u010ditom \u010dase. Viac inform\u00e1ci\u00ed o tom, ako sa v tomto obdob\u00ed vyu\u017e\u00edvali \u00fadaje o prevalencii, n\u00e1jdete v tomto pr\u00edklade od Agent\u00fary verejn\u00e9ho zdravia Severn\u00e9ho \u00cdrska:<a href=\"https:\/\/www.publichealth.hscni.net\/node\/5277\"> \u00dadaje o prevalencii v akcii po\u010das COVID-19<\/a>.<\/p>\n\n\n\n<h2><strong>V\u00fdznam v oblasti verejn\u00e9ho zdravia<\/strong><\/h2>\n\n\n\n<h3><strong>Monitorovanie trendov<\/strong><\/h3>\n\n\n\n<p>Incidencia a prevalencia s\u00fa d\u00f4le\u017eit\u00e9 na sledovanie trendov ochoren\u00ed a epid\u00e9mi\u00ed v popul\u00e1cii. Meranie v\u00fdskytu pom\u00e1ha \u00faradn\u00edkom verejn\u00e9ho zdravotn\u00edctva identifikova\u0165 nov\u00e9 pr\u00edpady ochorenia v priebehu \u010dasu, \u010do je nevyhnutn\u00e9 na v\u010dasn\u00e9 odhalenie ohn\u00edsk a pochopenie dynamiky prenosu ochorenia.&nbsp;<\/p>\n\n\n\n<p>Napr\u00edklad n\u00e1hly n\u00e1rast v\u00fdskytu prenosn\u00e9ho ochorenia, ako s\u00fa os\u00fdpky, m\u00f4\u017ee vyvola\u0165 okam\u017eit\u00fa reakciu, ktor\u00e1 zah\u0155\u0148a realiz\u00e1ciu o\u010dkovac\u00edch kampan\u00ed a z\u00e1sahov v oblasti verejn\u00e9ho zdravia. Naopak, prevalencia poskytuje preh\u013ead o tom, ako je choroba roz\u0161\u00edren\u00e1 v konkr\u00e9tnom okamihu, \u010do umo\u017e\u0148uje zdravotn\u00edckym org\u00e1nom monitorova\u0165 dlhodob\u00e9 trendy a posudzova\u0165 z\u00e1\u0165a\u017e chronick\u00fdch ochoren\u00ed, ako je cukrovka alebo hypertenzia. Anal\u00fdza oboch ukazovate\u013eov umo\u017e\u0148uje zdravotn\u00edckym pracovn\u00edkom identifikova\u0165 z\u00e1konitosti, hodnoti\u0165 \u00fa\u010dinnos\u0165 intervenci\u00ed a prisp\u00f4sobova\u0165 strat\u00e9gie na \u00fa\u010dinn\u00fa kontrolu chor\u00f4b.<\/p>\n\n\n\n<h3><strong>Pride\u013eovanie zdrojov<\/strong><\/h3>\n\n\n\n<p>Meranie incidencie a prevalencie m\u00e1 z\u00e1sadn\u00fd v\u00fdznam pre efekt\u00edvne pride\u013eovanie zdrojov v oblasti verejn\u00e9ho zdravia. Pochopenie v\u00fdskytu ochorenia umo\u017e\u0148uje zdravotn\u00edckym org\u00e1nom uprednostni\u0165 zdroje na prevenciu a kontrolu, ako je napr\u00edklad zameranie o\u010dkovania alebo kampan\u00ed zdravotnej osvety v oblastiach s vysok\u00fdm v\u00fdskytom nov\u00fdch infekci\u00ed. Naopak, \u00fadaje o prevalencii pom\u00e1haj\u00fa \u00faradn\u00edkom verejn\u00e9ho zdravotn\u00edctva pri pride\u013eovan\u00ed zdrojov na zvl\u00e1dnutie aktu\u00e1lnych potrieb zdravotnej starostlivosti.&nbsp;<\/p>\n\n\n\n<p>Napr\u00edklad vysok\u00e1 miera v\u00fdskytu por\u00fach du\u0161evn\u00e9ho zdravia v komunite m\u00f4\u017ee podnieti\u0165 miestne zdravotn\u00edcke syst\u00e9my, aby zv\u00fd\u0161ili financovanie slu\u017eieb v oblasti du\u0161evn\u00e9ho zdravia, napr\u00edklad poradensk\u00fdch alebo podporn\u00fdch programov. Celkovo tieto opatrenia umo\u017e\u0148uj\u00fa tvorcom polit\u00edk a poskytovate\u013eom zdravotnej starostlivosti prij\u00edma\u0165 informovan\u00e9 rozhodnutia o tom, kam nasmerova\u0165 finan\u010dn\u00e9 prostriedky, person\u00e1l a in\u00e9 zdroje na \u00fa\u010dinn\u00e9 rie\u0161enie najp\u00e1l\u010divej\u0161\u00edch zdravotn\u00fdch probl\u00e9mov, \u010d\u00edm sa zabezpe\u010d\u00ed, \u017ee komunity dostan\u00fa podporu, ktor\u00fa potrebuj\u00fa.<\/p>\n\n\n\n<h2><strong>Vytv\u00e1rajte vedecky presn\u00e9 infografiky za nieko\u013eko min\u00fat<\/strong><\/h2>\n\n\n\n<p><a href=\"https:\/\/mindthegraph.com\/science-figures\/?utm_source=blog&amp;utm_medium=cta-final&amp;utm_campaign=conversion\">Mind the Graph<\/a> umo\u017e\u0148uje vedcom vytv\u00e1ra\u0165 vedecky presn\u00e9 infografiky v priebehu nieko\u013ek\u00fdch min\u00fat. Bola navrhnut\u00e1 s oh\u013eadom na v\u00fdskumn\u00edkov a pon\u00faka pou\u017e\u00edvate\u013esky pr\u00edvetiv\u00e9 rozhranie, ktor\u00e9 zjednodu\u0161uje proces vizualiz\u00e1cie zlo\u017eit\u00fdch \u00fadajov a my\u0161lienok. V\u010faka rozsiahlej kni\u017enici prisp\u00f4sobite\u013en\u00fdch \u0161abl\u00f3n a grafick\u00fdch prvkov umo\u017e\u0148uje Mind the Graph vedcom efekt\u00edvne komunikova\u0165 v\u00fdsledky svojho v\u00fdskumu, \u010d\u00edm ich spr\u00edstup\u0148uje \u0161ir\u0161iemu publiku.<\/p>\n\n\n\n<p>V dne\u0161nom r\u00fdchlom akademickom prostred\u00ed je \u010das ve\u013emi d\u00f4le\u017eit\u00fd a schopnos\u0165 r\u00fdchlo vytv\u00e1ra\u0165 vysokokvalitn\u00e9 vizu\u00e1ly m\u00f4\u017ee v\u00fdrazne zv\u00fd\u0161i\u0165 vplyv vedeckej pr\u00e1ce. Platforma nielen\u017ee \u0161etr\u00ed \u010das, ale pom\u00e1ha aj zlep\u0161i\u0165 preh\u013eadnos\u0165 prezent\u00e1ci\u00ed, posterov a publik\u00e1ci\u00ed. \u010ci u\u017e ide o konferencie, pr\u00edspevky do \u010dasopisov alebo vzdel\u00e1vacie \u00fa\u010dely, Mind the Graph u\u013eah\u010duje transform\u00e1ciu zlo\u017eit\u00fdch vedeck\u00fdch konceptov do p\u00fatav\u00fdch vizu\u00e1lov, ktor\u00e9 maj\u00fa ohlas u kolegov aj \u0161irokej verejnosti.<\/p>\n\n\n\n<figure class=\"wp-block-image alignwide size-full\"><a href=\"https:\/\/mindthegraph.com\/science-figures\/?utm_source=blog&amp;utm_medium=cta-final&amp;utm_campaign=conversion\"><img decoding=\"async\" loading=\"lazy\" width=\"517\" height=\"250\" src=\"https:\/\/mindthegraph.com\/blog\/wp-content\/uploads\/2022\/04\/illustrations-banner.png\" alt=\"Propaga\u010dn\u00fd banner prezentuj\u00faci vedeck\u00e9 ilustr\u00e1cie dostupn\u00e9 na Mind the Graph, ktor\u00e9 podporuj\u00fa v\u00fdskum a vzdel\u00e1vanie pomocou vysokokvalitn\u00fdch vizu\u00e1lov.\" class=\"wp-image-15818\" srcset=\"https:\/\/mindthegraph.com\/blog\/wp-content\/uploads\/2022\/04\/illustrations-banner.png 517w, https:\/\/mindthegraph.com\/blog\/wp-content\/uploads\/2022\/04\/illustrations-banner-300x145.png 300w\" sizes=\"(max-width: 517px) 100vw, 517px\" \/><\/a><figcaption class=\"wp-element-caption\">Ilustr\u00e1cie banner propaguj\u00faci vedeck\u00e9 vizu\u00e1ly na <a href=\"https:\/\/mindthegraph.com\/science-figures\/?utm_source=blog&amp;utm_medium=cta-final&amp;utm_campaign=conversion\">Mind the Graph<\/a>.<\/figcaption><\/figure>\n\n\n\n<div class=\"is-content-justification-center is-layout-flex wp-container-1 wp-block-buttons\">\n<div class=\"wp-block-button\"><a class=\"wp-block-button__link has-background wp-element-button\" href=\"https:\/\/mindthegraph.com\/science-figures\/?utm_source=blog&amp;utm_medium=cta-final&amp;utm_campaign=conversion\" style=\"background-color:#7833ff\"><strong>R\u00fdchlej\u0161ie vytv\u00e1ranie infografiky<\/strong><\/a><\/div>\n<\/div>","protected":false},"excerpt":{"rendered":"<p>Zistite k\u013e\u00fa\u010dov\u00e9 rozdiely medzi incidenciou a prevalenciou, z\u00e1kladn\u00e9 ukazovatele na sledovanie trendov ochoren\u00ed a pl\u00e1novanie verejn\u00e9ho zdravia.<\/p>","protected":false},"author":35,"featured_media":55909,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":[],"categories":[974,961],"tags":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v19.9 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Incidence vs Prevalence: Key Metrics for Disease Measurement - Mind the Graph Blog<\/title>\n<meta name=\"description\" content=\"Learn the key differences between incidence and prevalence, essential metrics for tracking disease trends and public health planning.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/mindthegraph.com\/blog\/sk\/incidence-vs-prevalence\/\" \/>\n<meta property=\"og:locale\" content=\"sk_SK\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Incidence vs Prevalence: Key Metrics for Disease Measurement - Mind the Graph Blog\" \/>\n<meta property=\"og:description\" content=\"Learn the key differences between incidence and prevalence, essential metrics for tracking disease trends and public health planning.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/mindthegraph.com\/blog\/sk\/incidence-vs-prevalence\/\" \/>\n<meta property=\"og:site_name\" content=\"Mind the Graph Blog\" \/>\n<meta property=\"article:published_time\" content=\"2025-02-07T11:59:17+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-02-25T12:05:25+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mindthegraph.com\/blog\/wp-content\/uploads\/2025\/02\/incidence_vs_prevalence.png\" \/>\n\t<meta property=\"og:image:width\" content=\"1124\" \/>\n\t<meta property=\"og:image:height\" content=\"613\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Ang\u00e9lica Salom\u00e3o\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Ang\u00e9lica Salom\u00e3o\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"10 minutes\" \/>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Incidence vs Prevalence: Key Metrics for Disease Measurement - Mind the Graph Blog","description":"Learn the key differences between incidence and prevalence, essential metrics for tracking disease trends and public health planning.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/mindthegraph.com\/blog\/sk\/incidence-vs-prevalence\/","og_locale":"sk_SK","og_type":"article","og_title":"Incidence vs Prevalence: Key Metrics for Disease Measurement - Mind the Graph Blog","og_description":"Learn the key differences between incidence and prevalence, essential metrics for tracking disease trends and public health planning.","og_url":"https:\/\/mindthegraph.com\/blog\/sk\/incidence-vs-prevalence\/","og_site_name":"Mind the Graph Blog","article_published_time":"2025-02-07T11:59:17+00:00","article_modified_time":"2025-02-25T12:05:25+00:00","og_image":[{"width":1124,"height":613,"url":"https:\/\/mindthegraph.com\/blog\/wp-content\/uploads\/2025\/02\/incidence_vs_prevalence.png","type":"image\/png"}],"author":"Ang\u00e9lica Salom\u00e3o","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Ang\u00e9lica Salom\u00e3o","Est. reading time":"10 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/mindthegraph.com\/blog\/incidence-vs-prevalence\/","url":"https:\/\/mindthegraph.com\/blog\/incidence-vs-prevalence\/","name":"Incidence vs Prevalence: Key Metrics for Disease Measurement - Mind the Graph Blog","isPartOf":{"@id":"https:\/\/mindthegraph.com\/blog\/#website"},"datePublished":"2025-02-07T11:59:17+00:00","dateModified":"2025-02-25T12:05:25+00:00","author":{"@id":"https:\/\/mindthegraph.com\/blog\/#\/schema\/person\/542e3620319366708346388407c01c0a"},"description":"Learn the key differences between incidence and prevalence, essential metrics for tracking disease trends and public health planning.","breadcrumb":{"@id":"https:\/\/mindthegraph.com\/blog\/incidence-vs-prevalence\/#breadcrumb"},"inLanguage":"sk-SK","potentialAction":[{"@type":"ReadAction","target":["https:\/\/mindthegraph.com\/blog\/incidence-vs-prevalence\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/mindthegraph.com\/blog\/incidence-vs-prevalence\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/mindthegraph.com\/blog\/"},{"@type":"ListItem","position":2,"name":"Incidence vs Prevalence: Key Metrics for Disease Measurement"}]},{"@type":"WebSite","@id":"https:\/\/mindthegraph.com\/blog\/#website","url":"https:\/\/mindthegraph.com\/blog\/","name":"Mind the Graph Blog","description":"Your science can be beautiful!","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/mindthegraph.com\/blog\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"sk-SK"},{"@type":"Person","@id":"https:\/\/mindthegraph.com\/blog\/#\/schema\/person\/542e3620319366708346388407c01c0a","name":"Ang\u00e9lica Salom\u00e3o","image":{"@type":"ImageObject","inLanguage":"sk-SK","@id":"https:\/\/mindthegraph.com\/blog\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/a59218eda57fb51e0d7aea836e593cd1?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a59218eda57fb51e0d7aea836e593cd1?s=96&d=mm&r=g","caption":"Ang\u00e9lica Salom\u00e3o"},"url":"https:\/\/mindthegraph.com\/blog\/sk\/author\/angelica\/"}]}},"_links":{"self":[{"href":"https:\/\/mindthegraph.com\/blog\/sk\/wp-json\/wp\/v2\/posts\/55908"}],"collection":[{"href":"https:\/\/mindthegraph.com\/blog\/sk\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/mindthegraph.com\/blog\/sk\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/mindthegraph.com\/blog\/sk\/wp-json\/wp\/v2\/users\/35"}],"replies":[{"embeddable":true,"href":"https:\/\/mindthegraph.com\/blog\/sk\/wp-json\/wp\/v2\/comments?post=55908"}],"version-history":[{"count":1,"href":"https:\/\/mindthegraph.com\/blog\/sk\/wp-json\/wp\/v2\/posts\/55908\/revisions"}],"predecessor-version":[{"id":55910,"href":"https:\/\/mindthegraph.com\/blog\/sk\/wp-json\/wp\/v2\/posts\/55908\/revisions\/55910"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/mindthegraph.com\/blog\/sk\/wp-json\/wp\/v2\/media\/55909"}],"wp:attachment":[{"href":"https:\/\/mindthegraph.com\/blog\/sk\/wp-json\/wp\/v2\/media?parent=55908"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/mindthegraph.com\/blog\/sk\/wp-json\/wp\/v2\/categories?post=55908"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/mindthegraph.com\/blog\/sk\/wp-json\/wp\/v2\/tags?post=55908"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}